BRPI0415646A - vetores retrovirais para o suprimento de rna de interferência - Google Patents

vetores retrovirais para o suprimento de rna de interferência

Info

Publication number
BRPI0415646A
BRPI0415646A BRPI0415646-3A BRPI0415646A BRPI0415646A BR PI0415646 A BRPI0415646 A BR PI0415646A BR PI0415646 A BRPI0415646 A BR PI0415646A BR PI0415646 A BRPI0415646 A BR PI0415646A
Authority
BR
Brazil
Prior art keywords
rna
retroviral vectors
supply
interference
vectors
Prior art date
Application number
BRPI0415646-3A
Other languages
English (en)
Inventor
Dorre Grueneberg
Gerard Bain
Nayantara Kothari
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of BRPI0415646A publication Critical patent/BRPI0415646A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/867—Retroviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"VETORES RETROVIRAIS PARA O SUPRIMENTO DE RNA DE INTERFERêNCIA". O presente requerimento de patente de refere a vetores retrovirais e lentovirais, que compreendem um promotor para a polimerase RNA, um poli-ligante e um ácido nucléico que codifica para um RNA pequeno to tipo de grampo de cabelo (shRNA) específico para um gene alvo. Na ocasião da introdução do referido shRNA dentro de células, é induzida a degradação do RNA mensageiro do gene alvo através da interferência do RNA.
BRPI0415646-3A 2003-10-22 2004-10-21 vetores retrovirais para o suprimento de rna de interferência BRPI0415646A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51331303P 2003-10-22 2003-10-22
PCT/US2004/034932 WO2005042754A1 (en) 2003-10-22 2004-10-21 Retroviral vectors for delivery of interfering rna

Publications (1)

Publication Number Publication Date
BRPI0415646A true BRPI0415646A (pt) 2006-12-12

Family

ID=34549264

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415646-3A BRPI0415646A (pt) 2003-10-22 2004-10-21 vetores retrovirais para o suprimento de rna de interferência

Country Status (13)

Country Link
US (2) US7612195B2 (pt)
EP (1) EP1678312A1 (pt)
JP (1) JP2007508842A (pt)
KR (1) KR20060107519A (pt)
CN (1) CN1871356B (pt)
AR (1) AR046598A1 (pt)
AU (2) AU2004286231B2 (pt)
BR (1) BRPI0415646A (pt)
CA (1) CA2542871C (pt)
IL (1) IL174804A0 (pt)
MX (1) MXPA06004428A (pt)
TW (2) TWI350311B (pt)
WO (1) WO2005042754A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1844149A1 (en) * 2005-02-01 2007-10-17 Medical Research Council Screening method
US20090217397A1 (en) * 2006-06-12 2009-08-27 Patrick Stern Cre-lox based gene knockdown constructs and methods of use thereof
WO2008112226A2 (en) 2007-03-13 2008-09-18 Massachusetts Institute Of Technology Cre-lox based gene knockdown constructs and methods of use thereof
WO2010022553A1 (en) * 2008-08-25 2010-03-04 Institute Of Basic Medical Sciences, Chinese Academy Of Medical Sciences An endogenous short hairpin rna and the use of the same
US9481895B2 (en) 2011-09-23 2016-11-01 Ge Healthcare Dharmacon, Inc. Introduction of modular vector elements during production of a lentivirus
CN103060374B (zh) * 2012-10-30 2014-05-07 中国农业科学院兰州兽医研究所 一种基于位点特异性重组的rna干扰载体及其构建方法和应用
CN105586360A (zh) * 2016-03-04 2016-05-18 武汉科技大学 一种同时表达小分子rna和蛋白质的双功能慢病毒表达载体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624803A (en) * 1993-10-14 1997-04-29 The Regents Of The University Of California In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom
US6624803B1 (en) * 1995-10-20 2003-09-23 Wisconsin Alumni Research Foundation Interface for electronic devices providing improved access for people with disabilities
CN1429911A (zh) * 2001-12-30 2003-07-16 李卫云 慢病毒载体系统，产生载体的方法及其应用
AU2003224725A1 (en) * 2002-03-20 2003-10-08 Brigham And Women's Hospital, Inc. Hiv therapeutic
AU2003268546A1 (en) * 2002-09-06 2004-03-29 Massachusetts Institute Of Technology Lentiviral vectors, related reagents, and methods of use thereof
AU2003297474A1 (en) * 2002-12-18 2004-07-14 Salk Institute For Biological Studies Methods of inhibiting gene expression by rna interference

Also Published As

Publication number Publication date
US7884200B2 (en) 2011-02-08
MXPA06004428A (es) 2006-07-03
TW200523362A (en) 2005-07-16
AU2004286231A1 (en) 2005-05-12
AU2009248456B2 (en) 2011-09-15
TWI350311B (en) 2011-10-11
AU2009248456A1 (en) 2010-01-07
AR046598A1 (es) 2005-12-14
AU2004286231B2 (en) 2009-09-10
US20100028996A1 (en) 2010-02-04
CA2542871C (en) 2010-11-16
CA2542871A1 (en) 2005-05-12
IL174804A0 (en) 2006-08-20
EP1678312A1 (en) 2006-07-12
KR20060107519A (ko) 2006-10-13
CN1871356A (zh) 2006-11-29
TW201111508A (en) 2011-04-01
US7612195B2 (en) 2009-11-03
JP2007508842A (ja) 2007-04-12
WO2005042754A1 (en) 2005-05-12
CN1871356B (zh) 2011-04-27
US20060252153A1 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
BR0211111A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, transgene, precursor de rna engenheirado, animal transgênico não humano, e, método de induzir a interferência de ácido ribonucleico de um gene alvo em uma célula
PT1222292E (pt) Metodo para regulacao da transcricao de genes exogenos na presenca de azoto
EP4527459A3 (en) Nucleic acid, composition and conjugate containing nucleic acid, preparation method therefor and use thereof
GT200200010A (es) Pirimidinas inhibidoras de metaloproteinasas de matriz
WO2006135436A3 (en) Inhibition of gene expression and therapeutic uses thereof
GT200200017A (es) Inhibidores de metaloproteinasas de matriz basados en pirimidonas fusionadas
CL2009000082A1 (es) Acido nucleico que codifica anticuerpos anti cd79a o anti cd79b para el tratamiento de tumores hematopoyeticos; vector y células huésped que los comprenden; polipeptido codificado por dicho acido nucleico, inmunoconjugado con el cuerpo.
BRPI0819526B8 (pt) Sequência de ácido nucleico de precursor de mirna artificial, construção recombinante e método para reduzir a expressão de uma sequência alvo
BR0314138A (pt) composição, e, método
EA200870401A1 (ru) КОМПОЗИЦИИ И СПОСОБЫ ИНГИБИРОВАНИЯ ЭКСПРЕССИИ ГЕНА Eg5
NZ609903A (en) Expression vector for high level expression of recombinant proteins
DE50311850D1 (de) Konstrukte und verfahren zur regulation der genexpression
ZA200805739B (en) Anti-myosin Va sirna and skin depigmentation
BRPI0806252A2 (pt) molécula de ácido nucléico de promotor, vetor recombinante, célula de hospedeiro e método de expressão de gene alvo
CL2022000825A1 (es) Modificaciones químicas de arn pequeño de interferencia con contenido mínimo de flúor
ATE528008T1 (de) Rnai-modulation von aha und ihre therapeutische verwendung
ES2383716T3 (es) Composiciones y métodos que utilizan ARN de interferencia de un gen del tipo OPR3 para el control de nemátodos
BRPI0415646A (pt) vetores retrovirais para o suprimento de rna de interferência
EP1476459A4 (en) INHIBITION OF RNA INTERFERENCE-INDUCED CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
BR0313455A (pt) modulação "antisense" da expressão de nav1.3
CO2024013601A2 (es) Arnip que suprime la expresión del receptor de transferrina 2
BR0209551A (pt) Promotor de gene especìfico de folha de café
BRPI0519344A2 (pt) promotor induzÍvel por l-lisina
BR0212339A (pt) promotor 7s alfa especìfico para semente na expressão de genes em plantas
ATE450610T1 (de) Pflanzliche defensine

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: AVENTIS PHARMACEUTICALS, INC. (US)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070165509/RJ DE 23/11/2007.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]